Integer Holdings Co. ( NYSE:ITGR – Get Free Report ) has been assigned a consensus recommendation of “Moderate Buy” from the eight analysts that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company.
The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $139.75. ITGR has been the subject of a number of research analyst reports.
Benchmark raised their price objective on Integer from $130.00 to $140.00 and gave the company a “buy” rating in a research report on Monday, October 21st.
Citigroup raised their price target on Integer from $124.00 to $130.00 and gave the company a “neutral” rating in a report on Tuesday, October 1st.
Bank of America upped their price objective on Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a report on Tuesday, October 1st.
Piper Sandler reissued an “overweight” rating and issued a $140.00 target price (up from $125.00) on shares of Integer in a report on Friday, October 25th.
Finally, KeyCorp upped their price target on shares of Integer from $139.00 to $144.00 and gave the company an “overweight” rating in a research note on Tuesday, October 15th.
Read Our Latest Stock Report on Integer Institutional Inflows and Outflows Integer Price Performance NYSE:ITGR opened at $140.50 on Monday. The business’s 50-day simple moving average is $131.
38 and its two-hundred day simple moving average is $124.50. The company has a quick ratio of 2.
09, a current ratio of 3.28 and a debt-to-equity ratio of 0.67.
Integer has a 52 week low of $84.75 and a 52 week high of $142.00.
The stock has a market cap of $4.71 billion, a PE ratio of 43.36, a P/E/G ratio of 2.
01 and a beta of 1.09. Integer ( NYSE:ITGR – Get Free Report ) last released its quarterly earnings data on Thursday, October 24th.
The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.
07. Integer had a net margin of 6.70% and a return on equity of 11.
63%. The firm had revenue of $431.42 million for the quarter, compared to analysts’ expectations of $440.
59 million. During the same quarter last year, the business posted $1.27 earnings per share.
The company’s revenue for the quarter was up 8.7% compared to the same quarter last year. As a group, analysts forecast that Integer will post 5.
33 EPS for the current fiscal year. Integer Company Profile ( Get Free Report Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical.
The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. See Also Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter .
.
Business
Integer Holdings Co. (NYSE:ITGR) Receives Average Recommendation of “Moderate Buy” from Brokerages
Integer Holdings Co. (NYSE:ITGR – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the eight analysts that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 1 year [...]